西药公司（West Pharmaceutical Services Inc，股票代码：WST）今日盘中股价大涨27.51%，引起市场广泛关注。该公司发布了优于预期的第二季度业绩报告，并上调了2025财年的全年财务预期。
根据公司公布的财报，西药公司第二季度每股收益达到1.84美元，远高于分析师预期的1.51美元。第二季度销售额为7.665亿美元，同样超过分析师预期的7.275亿美元。强劲的业绩表现主要得益于GLP-1减肥药和糖尿病药物所用成分的需求强劲，以及美元走软的影响。
此外，西药公司还大幅上调了2025财年的利润和销售额预期。公司预计全年每股收益将在6.65美元至6.85美元之间，高于此前预期的6.15美元至6.35美元。同时，公司将全年销售额预期上调至30.4亿美元至30.6亿美元，此前预期为29.5亿美元至29.8亿美元。这一上调显示出公司对未来业务增长的信心，是推动股价大幅上涨的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.